hide
Free keywords:
INSULIN-SECRETION; GENE-EXPRESSION; QUANTITATIVE PROTEOMICS; PROLACTIN
RECEPTOR; PANCREATIC-ISLETS; HUMAN-PREGNANCY; CYCLOPHILIN-B; GROWTH;
MOUSE; MICEEndocrinology & Metabolism;
Abstract:
Diabetes is characterized by insulin insufficiency due to a relative paucity of functional beta-cell mass. Thus, strategies for increasing beta-cell mass in situ are sought-after for therapeutic purposes. Pregnancy is a physiological state capable of inducing robust beta-cell mass expansion, however, the mechanisms driving this expansion are not fully understood. Thus, the aim of this study was to characterize pregnancy-induced changes in the islet proteome at the peak of beta-cell proliferation in mice. Islets from pregnant and nonpregnant littermates were compared via 2 proteomic strategies. In vivo pulsed stable isotope labeling of amino acids in cell culture was used to monitor de novo protein synthesis during the first 14.5 days of pregnancy. In parallel, protein abundance was determined using ex vivo dimethyl labelling at gestational day 14.5. Comparison of the 2 datasets revealed 170 islet proteins to be up regulated as a response to pregnancy. These included several proteins, not previously associated with pregnancy-induced islet expansion, such as CLIC1, STMN1, MCM6, PPIB, NEDD4, and HLTF. Confirming the validity of our approach, we also identified proteins encoded by genes known to be associated with pregnancy-induced islet expansion, such as CHGB, IGFBP5, MATN2, EHHADH, IVD, and BMP1. Bioinformatic analyses demonstrated enrichment and activation of the biological functions: "protein synthesis" and "proliferation," and predicted the transcription factors HNF4 alpha, MYC, MYCN, E2F1, NFE2L2, and HNF1 alpha as upstream regulators of the observed expressional changes. As the first characterization of the islet-proteome during pregnancy, this study provides novel insight into the mechanisms involved in promoting pregnancy-induced beta-cell mass expansion and function.
